A previously unreleased Army assessment confirms that ICE’s newly purchased electric-shock gloves work by producing intense pain. What the public record still lacks is everything that should come before field deployment: published policies, independent oversight, and answers to 16 sitting senators.
What the Army Actually Found
The October 2024 Fort Leavenworth exercise produced rapid compliance, but it was not a medical safety study.
Army employees acting as combative prisoners stopped resisting within seconds of contact during the Fort Leavenworth exercise. Participants reported fatigue, soreness, and strong reluctance to risk a second shock.
According to the assessment, obtained by watchdog group American Oversight through a Freedom of Information Act lawsuit, simply seeing the device was enough to produce compliance in some cases. The effect reportedly intensified when skin was wet or oily, and one participant described lingering discomfort lasting roughly 30 minutes after contact.
This was a controlled military-prison simulation, not an immigration arrest, a detention facility intake, or a street-level protest. The study found that the gloves reduced the duration of physical confrontations and increased extraction efficiency in those specific scenarios. It did not establish whether those results transfer safely to the populations ICE actually encounters.
American Oversight executive director Chioma Chukwu said the assessment shows the gloves can cause “intense pain” and force compliance but does not establish that they are safe, according to ABC News reporting.
The Gap Between “De-Escalation” and Pain Compliance
ICE’s procurement language calls this a de-escalation device; the Army’s own findings describe something more direct.
The mechanism is pain. The framing is policy. Those are not the same thing.
Unlike a Taser, which temporarily disrupts muscle control, the GLOVE reportedly works by overloading peripheral nerve endings in the skin. ICE’s procurement records describe it as a “conductive distraction and de-escalation device,” but the Army study’s own data describes pain-induced compliance. ICE calls that outcome de-escalation. The Army’s findings describe a pain response.
ICE signed a $16.7 million contract in August 2026 to purchase 6,000 pairs from Kentucky-based Compliant Technologies LLC. The gloves were reported to cost $2,495 each, with the remaining contract value covering support equipment and services.
Sixteen Democratic senators, led by Sen. Catherine Cortez Masto of Nevada, asked ICE to cancel the purchase or provide a detailed explanation of intended use, training requirements, and safeguards. Cortez Masto has since said ICE did not respond to the request. White House border czar Tom Homan acknowledged that training and policy questions remain unresolved before deployment.
The manufacturer’s own instructions reportedly warn against using the gloves on children, pregnant women, and disabled people. The sources reviewed here do not identify a publicly disclosed procedure for how field agents will screen for those populations, including during civil immigration enforcement where encounters are often unplanned and fast-moving.
The device may leave no visible mark, which means accountability depends on documentation rather than physical evidence. The public record does not yet establish whether mandatory activation logging or an independent audit mechanism will be required.
The improvements needed are specific and achievable. They include published rules of engagement before any pairs ship to field agents, documented training requirements with third-party verification, an independent medical safety review conducted outside the military-prison context, mandatory reporting of every activation, and a formal contestation process for detainees.
What Comes Next
The Army confirmed the gloves produced rapid compliance in tested scenarios; that was never the central question.
The questions that remain are harder. Will ICE publish use-of-force rules before deployment? Who audits activations? What recourse exists for people subjected to a tool that may leave no mark and no automatic record?
The technology exists. A publicly disclosed oversight framework does not, at least not yet. That gap is where accountability now has to start.
